The ECG telemetry devices market is expected to reach US$ 3,783.48 million by 2028 from US$ 2,087.66 million in 2020; it is estimated to grow at a CAGR of 7.8% during 2021–2028.
The arrythmia monitoring devices market is projected to reach US$ 9,742.95 million by 2028 from US$ 6,212.59 million in 2021; it is expected to grow at a CAGR of 6.6% from 2021 to 2028.
The global Cardiac Monitoring & Cardiac Rhythm Management Devices Market will be worth USD 29.32 Billion by 2027, according to a current analysis by Emergen Research. The growth of this market can be attributed to the increasing prevalence of cardiovascular diseases among the aging population. The increasing investments for the research and development of cardiac monitoring & cardiac rhythm management devices to enhance the efficiency of the devices are most likely to drive the growth of the market. The emergence of advanced minimally invasive technologies is expected to fuel the development of cardiac monitoring & cardiac rhythm management devices over the forecast period.
Mobile cardiac telemetry (MCAT) refers to a real-time cardiac monitoring possessing the cutting edge technology to provide convenient and reliable monitoring of cardiac rate of patients with cardiac diseases. MCT monitoring devices are known to be advanced developed device that automatically detects and transmits ECG rhythms without patient participation to a distant diagnostic monitoring laboratory which generally takes up to 30 days.
The growing number of heart patients is a major driving factor for the Asia Pacific ECG telemetry devices market. The Asia Pacific ECG telemetric devices market, based on the location of testing is segmented into point of care testing and hospitals. Hospital segments hold a dominant share in the market. However, the handheld ECG telemetric devices are gaining attention in the current market scenario. Look for complete report: - http://www.apacmarket.com/top-market/asia-pacific-ECG-telemetry-devices-china-japan-malaysia-singapore-australia-india-market
The latest report of MarketsandMarkets forecast that Cardiac Rhythm Management Market reaches at $23.3 Billion by 2017 and major player currently is North America & Europe and future leaders are India and China.